Drug Recalls Will Be Announced Without Classification Under FDA Pilot
Executive Summary
FDA is pilot testing a program to speed notification of health care providers and patients about drug recalls.
You may also be interested in...
FDA Intends to Strengthen Recall Effectiveness Checks
McKinsey & Co. submitted its Recall Business Process Improvement Study to FDA last year and delivered its recommendations this April.